RAMZI BOUDINA via REUTERS
In Naples, on the weekend of the open day reserved for young people, only Pfizer and Moderna vaccines will be used. AstraZeneca has been suspended for now. Seven hundred cancellations arrived in Liguria in less than forty-eight hours. In other regions, however, it goes on regularly. The news of the 18-year-old girl in a coma after a dose of AstraZeneca and hospitalized at the San Martino Polyclinic in Genoa has shaken the whole of Italy but above all has reopened the debate within the Technical Scientific Committee. In fact, on the agenda of today’s meeting there was not the issue concerning the AstraZeneca vaccine administered to the youngest but following the cases of thrombosis which occurred especially in some young women, the issue landed in a disruptive manner on the table of the CTS which , tomorrow in the early afternoon, he will express himself by outlining a new strategy, probably excluding the lowest age groups.
The Regions are moving in no particular order and that is why, before the weekend, before the open days, the CTS will have to indicate to the Ministry of Health what to do and then it will be up to AIFA to issue a circular. The positions are already quite clear. The coordinator of the CTS and president of the Higher Health Council, Franco Locatelli, reminds Rainews24 that the viral vector vaccine is “already preferentially recommended for people over 60 years of age, because the relationship between the benefits deriving from vaccination and any risks become incremental with age and particularly favorable above this threshold “. However, this recommendation does not exclude administration to people under 60, quite the contrary. Massive vaccination is being carried out, especially of the very young. The scientist then underlines that there is “in these hours a supreme attention to catch all the signals that can alert you to any side effects”. In particular on what happened in Genoa. Just today a new case in Savona, where a 34-year-old girl was urgently operated for thrombosis.
Even more clear is the Undersecretary of Health Pierpaolo Sileri who invites the CTS to disseminate as soon as possible new recommendations regarding the use of AstraZeneca on young people. The government exponent assumes that today the circulation of the virus is much lower than in the past, this therefore allows the use of the viral vector vaccine to be limited to younger people if there are contraindications. “I’ll give an example – he says – if today we had a circulation of the virus of 20 cases per 10 thousand inhabitants, then going back about a month and a half compared to today, the risk of ending up in intensive care or death for one person 20 and 29 years would be 7 cases per 100 thousand inhabitants. Today, with a ten times lower incidence, the benefit risk is very low under 30 years ”. According to Sileri, the AstraZeneca vaccine should not be administered under the age of 30 or under 40, while a review should not be made above the age of 50, because the relationship between risks and benefits is undoubtedly, even with the current circulation, in favor of the benefit.
Scientists and virologists all seem to agree on the limitation, at the moment, of the use of AstraZeneca on younger people, especially women. Already tomorrow precise indications should arrive from the CTS, convinced that it is necessary to indicate age limits.